Schafer Cullen Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,446
| Closed | -$3M | – | 144 |
|
|
2020
Q4 | $3M | Sell |
6,446
-6,004
| -48% | -$2.82M | 0.04% | 121 |
|
|
2020
Q3 | $5.5M | Sell |
12,450
-562
| -4% | -$232K | 0.09% | 97 |
|
|
2020
Q2 | $4.71M | Buy |
13,012
+1
| +0% | +$335 | 0.07% | 103 |
|
|
2020
Q1 | $3.69M | Sell |
13,011
-2,312
| -15% | -$729K | 0.06% | 116 |
|
|
2019
Q4 | $4.98M | Sell |
15,323
-1,070
| -7% | -$324K | 0.06% | 118 |
|
|
2019
Q3 | $4.78M | Sell |
16,393
-4,370
| -21% | -$1.25M | 0.06% | 113 |
|
|
2019
Q2 | $6.04M | Sell |
20,763
-8,634
| -29% | -$2.38M | 0.07% | 106 |
|
|
2019
Q1 | $8.05M | Sell |
29,397
-322
| -1% | -$80.1K | 0.12% | 92 |
|
|
2018
Q4 | $6.65M | Sell |
29,719
-243
| -0.8% | -$57K | 0.1% | 102 |
|
|
2018
Q3 | $7.31M | Sell |
29,962
-830
| -3% | -$191K | 0.1% | 98 |
|
|
2018
Q2 | $6.38M | Sell |
30,792
-475
| -2% | -$101K | 0.08% | 104 |
|
|
2018
Q1 | $6.46M | Sell |
31,267
-108
| -0.3% | -$22.7K | 0.08% | 108 |
|
|
2017
Q4 | $5.96M | Sell |
31,375
-190
| -0.6% | -$36.4K | 0.07% | 112 |
|
|
2017
Q3 | $5.97M | Sell |
31,565
-610
| -2% | -$110K | 0.07% | 107 |
|
|
2017
Q2 | $5.61M | Sell |
32,175
-7,615
| -19% | -$1.28M | 0.07% | 104 |
|
|
2017
Q1 | $6.11M | Sell |
39,790
-340
| -0.8% | -$52K | 0.08% | 106 |
|
|
2016
Q4 | $5.66M | Sell |
40,130
-150
| -0.4% | -$22.1K | 0.08% | 111 |
|
|
2016
Q3 | $6.41M | Sell |
40,280
-340
| -0.8% | -$52.4K | 0.08% | 100 |
|
|
2016
Q2 | $6M | Sell |
40,620
-835
| -2% | -$123K | 0.07% | 100 |
|
|
2016
Q1 | $5.87M | Sell |
41,455
-580
| -1% | -$77.7K | 0.07% | 97 |
|
|
2015
Q4 | $5.96M | Sell |
42,035
-960
| -2% | -$128K | 0.07% | 101 |
|
|
2015
Q3 | $5.26M | Sell |
42,995
-510
| -1% | -$66.4K | 0.06% | 113 |
|
|
2015
Q2 | $5.64M | Sell |
43,505
-1,080
| -2% | -$141K | 0.06% | 128 |
|
|
2015
Q1 | $5.99M | Sell |
44,585
-732
| -2% | -$94.4K | 0.06% | 123 |
|
|
2014
Q4 | $5.68M | Sell |
45,317
-1,219
| -3% | -$148K | 0.07% | 110 |
|
|
2014
Q3 | $5.66M | Sell |
46,536
-254
| -0.5% | -$30.9K | 0.05% | 128 |
|
|
2014
Q2 | $5.52M | Sell |
46,790
-895
| -2% | -$105K | 0.05% | 152 |
|
|
2014
Q1 | $5.73M | Sell |
47,685
-159
| -0.3% | -$18.9K | 0.06% | 138 |
|
|
2013
Q4 | $5.33M | Sell |
47,844
-189
| -0.4% | -$18.8K | 0.05% | 146 |
|
|
2013
Q3 | $4.43M | Sell |
48,033
-1,144
| -2% | -$103K | 0.05% | 162 |
|
|
2013
Q2 | $4.16M | Buy |
+49,177
| New | +$4.09M | 0.05% | 160 |
|
Other funds holding TMO
Schafer Cullen Capital Management's TMO Position: Q1 2021 in Review
Schafer Cullen Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 6,446 shares — an estimated $3M sold.
Schafer Cullen Capital Management first reported a position in TMO in Q2 2013 and held it in 31 quarters. The position peaked at $8.05M in Q1 2019. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.
- Schafer Cullen Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
- Schafer Cullen Capital Management sold 6,446 Thermo Fisher Scientific shares in Q1 2021, an estimated $3M.
- Schafer Cullen Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 31 quarters.
- Schafer Cullen Capital Management's Thermo Fisher Scientific position peaked at $8.05M in Q1 2019.
- 2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.
Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.